Skip to main content
Clinical Trials/NCT06418373
NCT06418373
Completed
Not Applicable

Development and Polit Study of an Intervention Program to Enhance the Transition Readiness of Adolescents With Congenital Heart Disease

Children's Hospital of Fudan University1 site in 1 country30 target enrollmentJune 26, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Transition to Adult Care
Sponsor
Children's Hospital of Fudan University
Enrollment
30
Locations
1
Primary Endpoint
Self-Management and Transition to Adulthood with Rx = Treatment (STAR(x)) Questionnaire
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trial is to learn if the Get Ready with my Heart Program developed based on SMART theory is applicable for AYAs with CHD to enhance their Transition Readiness. The main questions it aims to answer are:

  1. Is the Get Ready with my Heart Program clinically feasible?
  2. Does the Get Ready with my Heart Program improve participants' Transition Readiness?

Participants will:

  1. The intervention group will receive interventions according to the Get Ready with my Heart Program, while the control group will receive standard interventions.
  2. Outcome measures will be collected before the implementation of the program, and at 3 months and 6 months after the implementation.

Detailed Description

China currently has the highest number of congenital heart disease (CHD) patients in the world, placing a heavy disease burden on the country. As the number of adolescent CHD patients continues to grow, the strain on pediatric healthcare systems increases significantly, which in turn imposes a serious disease burden on families and society. Over the past thirty years, the overall health of children and adolescents in China has greatly improved, but they are now facing new health issues and societal challenges. For example, unhealthy lifestyle behaviors are prevalent, and mental health issues are on the rise. Additionally, as treatment levels have improved, the focus of congenital heart disease care has shifted from simply improving survival rates to enhancing management throughout the entire lifecycle and overall prognosis. Effective transitional care management not only helps improve patients' self-management abilities and adherence to treatment but also reduces the socio-economic burden and enhances patients' quality of life. However, studies show that only a minority of adolescent CHD patients successfully complete this transition, highlighting the urgent need to strengthen transitional care management. The purpose of this clinical pilot trial is to verify the feasibility and effectiveness of a management program designed to improve the transition readiness of adolescents with congenital heart disease based on the SMART model.

Registry
clinicaltrials.gov
Start Date
June 26, 2024
End Date
February 28, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between 12 and 21 years;
  • Diagnosed with congenital structural heart disease for at least 6 months;
  • Regularly receiving outpatient follow-up at Fudan University Children's Hospital;
  • Cognitive abilities corresponding to age, with adequate reading and comprehension skills;
  • Informed consent provided.

Exclusion Criteria

  • Patients with physical conditions that limit participation (e.g., severe heart failure);
  • Presence of other congenital malformations (e.g., various syndromes caused by chromosomal abnormalities);
  • Patients with psychiatric disorders such as schizophrenia, intellectual disabilities, visual impairments, or other conditions that preclude participation in the study.

Outcomes

Primary Outcomes

Self-Management and Transition to Adulthood with Rx = Treatment (STAR(x)) Questionnaire

Time Frame: before,3 and 6 months after intervention

Evaluate the transition readiness levels of adolescent CHD patients using the Chinese version of Self-Management and Transition to Adulthood with Rx = Treatment (STAR(x)) . The questionnaire includes a total of 13 items across three categories: self-management (5 items), disease knowledge (3 items), and patient-doctor communication (5 items). It uses a 5-point Likert scale ranging from "never" to "always" or "very difficult" to "very easy," with scores assigned from 1 to 5 respectively. The maximum score and minimal score for the questionnaire is 65 points and 13 points, , with higher scores indicating higher levels of self-management and transition readiness. The questionnaire is available in both parent-reported and self-reported versions, to be filled out by the adolescent CHD patients and their primary caregivers, with consistent assessment content and scoring methods.

Secondary Outcomes

  • Health-related quality of life for adolescent CHD patients(before and 6 months after intervention)
  • Transition skill levels for adolescent CHD patients-- General Self-Efficacy(before and 6 months after intervention)
  • Transition skill levels for adolescent CHD patients--Knowledge(before and 6 months after intervention)

Study Sites (1)

Loading locations...

Similar Trials